COPD Trial, Recruiting NCT05297279 Sponsor: Johns Hopkins University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT05297279
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 40 years of age or older
  • People who have been diagnosed with COPD (a lung disease) by a doctor
  • People whose COPD falls into a moderate-to-very-severe range, based on specific breathing test results (a breathing test showing certain airflow and lung capacity measurements, along with a symptom score of 10 or more in some cases — confirm with trial site if unsure)
  • People who have smoked at least 10 pack-years (for example, one pack of cigarettes per day for 10 years, or an equivalent amount)
  • People who live in a neighborhood where at least 10% of residents live in poverty, OR who do not have private health insurance, OR who completed high school as their highest level of education
  • People who currently consume less than 500mg per day of omega-3 fatty acids (EPA and DHA combined) from food and/or supplements
  • People who are willing to follow dietary recommendations during the study

Who may not be able to join:

  • People who are planning to move to a different home during the study period
  • People who have another ongoing lung disease (though people with a history of asthma may still be considered, if the treating doctor does not consider asthma to be their main diagnosis)
  • People who are pregnant or breastfeeding
  • People who are unwilling to eat seafood

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nadia Hansel, MD, MPH, Johns Hopkins University

Phone: 410-550-2449

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2022
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in COPD health status as assessed by the COPD assessment test; Change in COPD health status/health-related quality of life as assessed by the Clinical COPD Questionnaire health-related quality of life questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov